Chadwick Jonathan

Director Chadwick Jonathan sold 25,000 ZM shares at $74.86 (1.9M value); now holds 5.9K shares post-conversion

Chadwick Jonathan, a director, sold 25,000 shares of Zoom at $74.86 on 2025-07-15, reducing his direct holdings by 81.0% to 5.9K shares. The transaction occurred when the stock was trading -16.4% from its 52-week high, and comes amid the director's cross-ticker track record showing a 35.29% well-timed rate on prior sells with an average 90-day post-sale return of +2.6%. At ZM specifically, both of his two prior sales in January 2025 were well-timed at the 90-day mark, suggesting a pattern of selling ahead of subsequent declines. The current stock price of $74.44 is only 0.6% below the transaction price, but the -4.4% decline over the past 30 days warrants monitoring against this director's demonstrated timing pattern. Note: This filing reflects a derivative conversion; Table II derivative holdings are not yet populated in our database, so the 5.9K shares post-transaction do not represent the insider's complete position.

Director Chadwick Jonathan sold 34.4K CFLT shares at $30.57 (Feb 2025), reducing stake to 22.7K shares; stock now at $31.69.

Chadwick Jonathan, a Director, sold 34,375 shares of Confluent at $30.57 on 2025-02-25, reducing his holdings by 60.2% to 22,688 shares remaining. The sale occurred at a price 3.5% below the current market price of $31.69 and near the middle of the 52-week range ($18.67–$37.65). His cross-ticker track record shows 16 prior open-market sells with an 8.33% well-timed rate and a 90-day average return of +9.9%, indicating his past sales have been poorly timed—the stock typically rose after he sold. At CFLT specifically, his prior December 2024 sale has not yet reached the 90-day measurement window. The company remains unprofitable (net income of $-74.1M in the latest quarter) despite 24.0% annual revenue growth, which may provide context for the insider's decision-making. This appears to be a derivative-conversion transaction involving the settlement of convertible securities, rather than a discretionary liquidation of his equity stake.

Director Chadwick Jonathan sold 25,000 shares of ZM at blended avg $80.33, retaining 1,514 shares post-transaction.

Director Chadwick Jonathan executed 2 separate sales totaling 25,000 shares for $2,008,194.92 on 2025-01-15 at prices near the 52-week high ($80.10 and $80.56 versus 52-week high $89.03). The sale reduced his holdings by 94.3% to 1,514 shares. A FLAG in the filing indicates this involves a derivative-conversion transaction, meaning the insider's full economic position includes derivative securities not yet visible in the database, so this should not be read as a complete exit. Across his open-market history, his 14 prior sales show a 90d well-timed rate of 8.33%, and this current sale occurs within the stock's recent downtrend (-4.8% over 30 days, -12.3% from 52-week high), providing limited immediate context on execution quality relative to his historical pattern.

Director Chadwick Jonathan sold 22,500 shares of Samsara (IOT) at $45.37 on 2024-12-26, reducing stake 5.4% while stock down 17.9% in 30 days.

Director Chadwick Jonathan sold 22,500 shares at $45.37, reducing his holdings from 418,579 to 396,079 shares. The sale occurred as the stock has declined 17.9% over the past 30 days and 22.1% from its 52-week high of $56.35, currently trading at $43.91. Notably, his cross-ticker track record shows prior sells were poorly-timed on average—averaging +9.9% 90-day returns (meaning he sold and the stocks subsequently rose), with only an 8.33% well-timed rate. Against this backdrop, the current transaction enters a deteriorating price environment; whether this represents a departure from his pattern or structural conviction about Samsara specifically requires deeper examination of same-ticker history. The company remains unprofitable (net income $-37.8M) despite strong topline growth (+43.6% annual revenue growth) and $322.0M quarterly revenue, leaving ambiguity around the sale's motivation in a high-growth but loss-making context.

Director Chadwick Jonathan sold 34,375 shares of CFLT at $32.69, reducing position by 60.2%; stock now -9.6% from 52-week high.

Director Chadwick Jonathan sold 34,375 shares (34.4K shares) of Confluent at $32.69 on 2024-12-09 for $1,123,718.75 ($1.1M), reducing his holdings from 57,063 shares (57.1K shares) to 22,688 shares (22.7K shares)—a 60.2% reduction of his pre-transaction position. The sale occurred near the stock's 52-week high of $34.53, with the current price at $31.20 representing a -9.6% decline from that peak. Confluent remains unprofitable (net income of $-74.1M in the latest full fiscal year) despite strong revenue growth of +32.6% (FY vs prior FY), and the latest quarter showed revenue of $250.2M against net income of $-74.1M. This substantial reduction in a director's stake warrants investor attention given the unprofitable profile and the proximity to recent highs, though the derivative-conversion nature of this filing means the reported Table I holdings do not represent the full extent of the insider's economic position in the company.

Director Chadwick Jonathan sold 3,391 shares ($2.7M) of NOW at $801.00 on 2024-07-30; retains 3,975 shares post-sale.

Chadwick Jonathan, a Director, sold 3,391 shares representing 46.0% of his pre-transaction holdings. The sale occurred at $801.00 per share, and his cross-ticker track record shows a 90-day well-timed rate of 0.00%, indicating that his prior sales have not historically preceded declines in the stocks he sold. ServiceNow's fundamentals remain solid, with annual revenue growth of 23.8% and a quarterly revenue of $2,627,000,000.00, though the P/E of 29.29 reflects valuation premium typical of high-growth software names. The transaction warrants observation, but the lack of clustering or schedule information limits the available interpretation signals.